The prototypal AusDiab study 1 has shown that type II diabetes mellitus is common, costly and that its incidence is rising in Australia.
Two hundred and seventy-five Australian adults develop diabetes every day 1 . Prevalence varies from 7.5% in people over 25 to 23.6% in people over 75 1 . Diabetes is already a major health burden. The problem is also getting bigger: the number of people with diabetes has doubled since 1981 1 and, at current projections, will double again by 2025.
Diabetes is expensive to treat with an average of AUD$10,900 2 per annum spent for every patient with diabetes. Lacking Australian data makes it difficult to estimate cost that is over and above matched controls without diabetes. However, data from the United States suggests that the annual spend on persons with diabetes is 2.4 times that of age and sex-matched controls 3 .
Much is known about the long-term complications of diabetes. Little research has focused on the acute complications of diabetes in the intensive care unit (ICU), in particular acute kidney injury (AKI) and the need for renal replacement therapy (RRT).
AKI commonly complicates the course of critical illness 4 and is associated with a high mortality 5 . AKI is multifactorial in origin. These factors include renal hypoperfusion, sepsis and direct nephrotoxicity 4 . AKI is more likely to occur in patients with diabetes, regardless of prior renal disease 6 .
Previous research has shown an association between diabetes and the need for RRT. However, such research has been limited either by considering diabetes as part of a group of comorbidities and not as an independent risk factor 7 or considering only those patients who require insulin 8 . Other research has shown an increase in postoperative RRT but only in patients with chronic renal disease, as opposed to diabetes specifically 9 .
This study investigated whether diabetic status is an independent risk factor for haemofiltration in the ICU.
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METHODS

Study design and data collection
Dataset and patient selection
All admissions from 1 January 2004 to 31 December 2010 were used. There was no significant difference in care during these six years. Multiple admissions for the same patient were excluded -in this case, only the first admission data was used. Any subsequent admissions, either in the same hospitalisation or a future hospitalisation, were not included.
Patients already receiving dialysis prior to their hospital stay, regardless of diabetic status, were excluded.
Diabetic status was defined as being present or not based on the patient's history. Formal testing of fasting glucose or HbA1c were not performed. Diabetic severity, e.g. retinopathy, neuropathy, was not recorded in the dataset.
Outcome measures
We hypothesised that diabetic status might be an independent risk factor for haemofiltration. Haemofiltration status for each patient was a binary variable based on whether the patient had haemofiltration. Haemofiltration was not initiated based on standardised criteria. Rather, it was at the discretion of the treating consultant. The specific type of haemofiltration used was continuous venovenous haemodiafiltration.
Statistical analysis
Mann-Whitney U tests were used for significance testing when comparing medians. Unadjusted Pearson chi-square tests were used for comparisons of nominal values.
Binary logistic regression was used to determine whether there was an association between diabetic status and haemofiltration. Independent variables were chosen based on clinical grounds (as determined by a consultant), step-wise forward regression for significance and prior research identifying the following variables: AKI on admission, age, hypertension, prior acute myocardial infarction 3 , chronically elevated creatinine (>176.8 μmol/l), inotrope usage during admission 10 and Acute Physiology and Chronic Health Evaluation III score 11 .
Admitting diagnosis was transposed from a categorical (no rank) variable of 81 possibilities to a binary variable. This transposition was chosen retrospectively using consultant opinion and prior research identifying several diagnoses that are associated with a greater risk of AKI and potentially a confounder for haemofiltration. These diagnoses included sepsis 12 , trauma 13 , cardiac arrest and cardiogenic shock 14 , renal diseases 8 and vascular surgery including aortic aneurysm 15 . This variable will be referred to as 'renal risk diagnosis'.
Omnibus test was used for model significance. Nagelkerke R squared values were calculated for model variance. Area under the receiver operating curve figures were used for model discrimination.
A two-tailed P-value <0.05 was defined as the level of statistical significance, and 95% confidence intervals were used where appropriate. Statistical 
RESULTS
There were 7931 patients in the data set, of which 7400 were unique. Of the 7400 unique patients, 138 were already on dialysis treatment. This left 7262 patients, of which there were 1674 patients with diabetes (23.1%) and 5588 without diabetes (76.9%). Median age in the patient group with diabetes was 69 (interquartile range 61 to 75) versus 64 (interquartile range 50 to 73) in the patient group without diabetes. Of the 1674 patients with diabetes, 1117 were male (66.72%). Of the 5588 patients without diabetes, 3584 were male (64.13%).
There was a significant difference in haemofiltration between the two groups. The difference remained, even allowing for various confounding variables including Acute Physiology and Chronic Health Evaluation III, a history of acute myocardial infarction or hypertension, chronically elevated creatinine and an admitting diagnosis being a 'renal risk'. A total of 517 patients received haemofiltration. This represents 159 patients with diabetes (159 of 1674 or 9.49%) versus 358 patients without diabetes (358 of 5588 or 6.40%). Diabetic status was an independent risk factor for haemofiltration (odds ratio 1.401, 95% confidence interval 1.079 to 1.820, P=0.011, logistic regression, Nagelkerke R squared 0.465, area under the receiver operating curve =0.930, (area under the receiver operating curve confidence interval 0.920 to 0.940).
DISCUSSION
The findings of this study show that diabetic status was an independent risk factor for haemofiltration at a major Melbourne ICU. There were some differences between the patients with diabetes and those without. Patients with diabetes were more likely to have a chronic elevation in creatinine or have a history of renal disease. These variables were controlled for in the regression and still diabetic status was independently associated with a higher rate of haemofiltration.
Diabetes is increasingly prevalent in Australia. Haemofiltration units are expensive to buy and run. Whilst this is not an economic study, it would seem reasonable to extrapolate that the cost of running an ICU will likely rise as the prevalence of diabetes also rises. The public health system will end up bearing this cost.
In addition, there are likely significant impacts to individual patients. A patient who suffers from AKI is more likely to suffer morbidity in the ICU 4, 16 . Longer term, AKI is associated with higher rates of chronic kidney disease, cardiovascular disease and mortality 17 .
What might the implications be for the prevention of AKI in patients with diabetes? Prior research has identified many renoprotective strategies including ensuring adequate circulating volume 17 , minimising, avoiding or ameliorating contrast load 18 in imaging and avoiding nephrotoxic drugs 19 . How these strategies apply specifically to diabetic patients in the ICU is less clear.
For contrast-induced nephropathy (CIN), simply having diabetes was not associated with an increase in CIN 19 . CIN was associated with underlying kidney disease that is more likely to exist in diabetic patients 20 . Consequently more aggressive CIN prophylaxis does not seem warranted purely based on diabetic status.
This may not be the case for circulating volume and nephrotoxic drugs. It has been well validated that adequate circulating volume is renoprotective 4 . It is conceivable that more aggressive fluid regimes may reduce the rates of AKI and RRT specifically in ICU patients with diabetes. This may warrant a lower threshold for placement of central venous catheters in patients with diabetes for better central venous pressure management, although this topic itself is fraught with controversy and may not help identify fluid responders 21 . Notably, patients with diabetes in this study had higher rates of central venous pressure monitoring. Unfortunately, such research is lacking and is outside the scope of this paper.
Lower estimated glomerular filtration rate is associated with longer length of stay 22 , increased mortality 23 and, presumably, higher rates of haemofiltration. It is possible that the higher rates of haemofiltration in this study are confounded by the higher rates of prior kidney disease in the diabetic group. This study attempted to control for the higher rates of renal disease in the group with diabetes by having prior renal disease as a covariable in the regression analysis. This is similar to Girman et al 6 who found higher rates of AKI in patients with diabetes even allowing for previous kidney disease. However, having estimated glomerular filtration rate as a covariate would have been useful. Unfortunately this data was not available.
Specific inotropes, such as dobutamine, for renoprotective measures have shown to be ineffective 24 . Despite this, there was a significantly higher rate of dobutamine use in the patients with diabetes.
Despite the large sample size, there are many limitations of this study. Transferability is limited as this was a single-centre study. Diabetic status was either present or not. No differentiation was made by the type of diabetes (e.g. gestational, type I or type II) or the severity of the disease, i.e. insulin-dependent, HbA1c, time since diagnosis, although severity was somewhat accounted for by other variables present in the study including past history of myocardial infarction. Diabetic status was based upon patient history and was not formally tested prior to inclusion.
The decision to initiate renal replacement therapy lacks consensus [25] [26] [27] and consistency 28 amongst intensivists. There was no predefined criteria for initiating RRT in this study. It is possible that RRT was withheld in one group more than the other. Previous research 29 has found that diabetic status was not a significant influence on whether to withhold RRT. RRT may be initiated for other clinical indications including fluid overload and hyperkalaemia. Diabetics have a higher risk of type IV renal tubular acidosis 30 and hence, hyperkalaemia. It is possible that this is a confounder in the group with diabetes. Unfortunately, data for pre-RRT potassium levels did not exist and this possible confounder could not be adjusted for. Likewise, there are many other factors that are known to be associated with AKI (and possibly haemofiltration requirement) that we have not allowed for in the regression.
The choice of hydroxyethyl starch fluid has been associated with a higher rate of RRT 31 . Data on the choice of resuscitation fluid was not available.
CONCLUSION
Patients with diabetes were more likely to require haemofiltration in the studied ICU, even allowing for AKI and other risk factors. Prior research has identified renoprotective methods for ICU patients but lacks specifics for at-risk groups, including patients with diabetes. Further research would be useful to assess any benefit in reducing AKI and RRT in patients who have diabetes.
